Staples, J. N., Peres, L. C., Camacho, F., Alberg, A. J., Bandera, E., Barnholtz-Sloan, J., … Schildkraut, J. M. (2020). Assessing the impact of cardiometabolic risk on ovarian cancer survival among African-American women in the African-American cancer epidemiology study (AACES). In Gynecologic Oncology (Vol. 159, pp. 157–158). Elsevier BV. https://doi.org/10.1016/j.ygyno.2020.05.226

Staples, J. N., L. C. Peres, F. Camacho, A. J. Alberg, E. Bandera, J. Barnholtz-Sloan, M. L. Bondy, et al. “Assessing the impact of cardiometabolic risk on ovarian cancer survival among African-American women in the African-American cancer epidemiology study (AACES).” In Gynecologic Oncology, 159:157–58. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.05.226.

Staples JN, Peres LC, Camacho F, Alberg AJ, Bandera E, Barnholtz-Sloan J, et al. Assessing the impact of cardiometabolic risk on ovarian cancer survival among African-American women in the African-American cancer epidemiology study (AACES). In: Gynecologic Oncology. Elsevier BV; 2020. p. 157–8.

Staples, J. N., et al. “Assessing the impact of cardiometabolic risk on ovarian cancer survival among African-American women in the African-American cancer epidemiology study (AACES).” Gynecologic Oncology, vol. 159, Elsevier BV, 2020, pp. 157–58. Crossref, doi:10.1016/j.ygyno.2020.05.226.

Staples JN, Peres LC, Camacho F, Alberg AJ, Bandera E, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Schildkraut JM. Assessing the impact of cardiometabolic risk on ovarian cancer survival among African-American women in the African-American cancer epidemiology study (AACES). Gynecologic Oncology. Elsevier BV; 2020. p. 157–158.